Day 1: Morning Coffee Break (Visiting professor Dr. Amy Boyle)
10:25-10:35am Oaikhena Esezobor Postdoctoral Fellow, Radiochemistry, Centre for Addiction and Mental Health (CAMH), Toronto Iron-Catalyzed Three-Component Synthesis of Radiofluoroamines
10:35 – 10:45am Alessia Pileggi MSc in Pharmaceutical Sciences, University of Toronto Theranostic 155Tb- and 225Ac-Labelled Trastuzumab F(ab’)2 for HER2-Positive Cancers
Day 1: Lunch (Visiting professor Dr. Joseph Lau)
12:45-12:55pm Jadon Khouv MSc Yr 2 with focus in radiopharmaceuticals, Simon Fraser University Synthesis, characterization, and evaluation of lanthanum-132/135 and actinium-225 chelators for radiopharmaceuticals
12:55-1:05pm Nancy Kim MSc Yr 2, Institute Medical Science, University of Toronto Preclinical evaluation of the novel radiotracer [11C]AMG487
Day 1: Afternoon Coffee Break (visiting professor Dr. Mina Swiha)
3:00-3:10pm Dominic Simpson Postdoctoral Yr 2, Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto [18F]SynVesT-1 PET Imaging of SV2A in Orthotopic Glioblastoma Mouse Models to Detect Tumour-Associated Changes in Synaptic Density Following Neuronal Inhibition
3:10-3:20pm Nikki Wong Nuclear Medicine and Molecular Imaging Technology Yr 3, Dept Radiation Oncology, University of Toronto Comparison of Radiation Exposure and Workflow Efficiency Between Administrations for Pluvicto
Day 1: Reception (visiting professor Dr. David Green)
5:20-5:30pm Michael Valic Post Doctoral Yr 1, University Health Network, Toronto Porphyrin-lipid nanotheranostics for the management of neck metastases
5:30-5:40pm Yumeela Ganga-Sah Post Doctoral Yr 2, Life Sciences, TRIUMF Production of Mercury-197 (m/g) for Targeted Auger Electron Therapy
5:40 – 5: 50pm Marianna Tosato Post Doctoral Yr 5, Simon Fraser University Toward Universal Chelators for Radiolanthanide and Radioactinide-Based Theranostics
Day 2: Morning Coffee Break (visiting professor Dr. Duncan Sutherland)
10:15 -10:25am Henry Wong Radiation Oncology Fellow Yr 1, Department of Radiation Oncology, University of Toronto Early Response Assessment of 177Lu-DOTATATE in Neuroendocrine Tumors Using Choi versus RECIST Criteria: Insights from the OZM-067 Trial
10:25 – 10:35am Filip Markovic Nuclear Medicine Residency Program, Yr 3, University of Western Ontario Validation of the Prostate PRIMARY Score on [18F] F-PSMA 1007 in High-Risk Prostate Cancer Patients
Day 2: Lunch (visiting professor Dr. Ivan Yeung)
12:35 – 12:45pm Sama Al-Salihi Nuclear Radioisotope Research Program Yr 1, McMaster University Production of PET isotope Lanthanum-133 at McMaster University Cyclotron Facility
12:45 – 12:55 pm Maziar Sabouri PhD candidate Yr 3, Department of Physics & Astronomy, University of British Columbia PBPK-based Digital Twins for Predictive Dosimetry in PSMA Radiopharmaceutical Therapy: A Virtual Theranostic Trial Study